THE USE OF ENDOCRINE THERAPY

被引：28

作者：

PRITCHARD, KI ^{[1
]}

SUTHERLAND, DJA ^{[1
]}

机构：

[1] SUNNYBROOK MED CTR,TORONTO M4N 3M5,ONTARIO,CANADA

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1989年 / 3卷 / 04期

关键词：

D O I：

10.1016/S0889-8588(18)30531-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：765 / 805

页数：41

共 364 条

[61]

COOMBES RC, 1985, CANCER TREAT REP, V69, P351

[62]

COOMBES RC, 1983, CANCER CHEMOTH PHARM, V10, P194

[63] 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER [J].

COOMBES, RC ;

GOSS, P ;

DOWSETT, M ;

GAZET, JC ;

BRODIE, A .

LANCET, 1984, 2 (8414) :1237-1239

[64]

CORKERY J, 1982, Cancer Research, V42, p3409S

[65] ORAL 4-HYDROXYANDROSTENEDIONE, A NEW ENDOCRINE TREATMENT FOR DISSEMINATED BREAST-CANCER [J].

CUNNINGHAM, D ;

POWLES, TJ ;

DOWSETT, M ;

HUTCHISON, G ;

BRODIE, AMH ;

FORD, HT ;

GAZET, JC ;

COOMBES, RC .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) :253-255

[66]

DAO T L, 1982, Cancer Research, V42, p3338S

[67] ABLATION THERAPY FOR HORMONE-DEPENDENT TUMORS [J].

DAO, TL .

ANNUAL REVIEW OF MEDICINE, 1972, 23 (05) :1-+

[68]

DAO TL, 1982, CANCER RES, V42, P359

[69]

DAVILA E, 1982, P AM SOC CLIN ONCOL, V1, P76

[70]

DELLACUNA GR, 1981, 12TH P INT C CHEM FI, V11, P1479

← 2 3 4 5 6 7 8 9 10 11 →